Boehringer Ingelheim wins Frost & Sullivan Award for Biopharmaceutical Contract Manufacturing
Ingelheim, Germany, September 7,
2011 – Boehringer Ingelheim today announced that is
has received the '2011 European Bio Pharmaceutical Contract
Manufacturing Competitive Strategy Leadership Award' from Frost
& Sullivan.
The analysts recognized Boehringer Ingelheim Biopharmaceuticals as
a global contract manufacturer who delivers excellence and best
practices to its customers and collaboration partners. The
Boehringer Ingelheim performance was measured against key
competitors in the same market focusing on the criteria: leverage
of competitive intelligence, execution of competitive strategy,
impact on market share, competitive brand positioning and impact on
customer satisfaction and value.
"This award is an important recognition for our contract
manufacturing organization and a great confirmation for continued
drive to put our customers first", stated Simon Sturge, Corporate
Senior Vice President Biopharmaceuticals at Boehringer Ingelheim.
"We will not rest on our laurels and will continue to further
improve our customer services to also deliver reliable and best
quality in the future. With our newly acquired biopharma
development- and manufacturing facility in Fremont, California,
Boehringer Ingelheim has already taken the next important step to
further strengthen our global customer orientation and
flexibility".